Considering that many androgen-insensitive PCa cases express AR, comparing androgen-sensitive, AR-positive LNCaP cells with PC-3/DU145 cell lines may be irrelevant in terms of acquisition of androgen insensitivity in clinical PCa [18]. The gene discussed is AR; the disease is posterior cortical atrophy.